Rare Neurological Disease Treatment Market, By Drug Type (Biologics and Small Molecules), By Mode of Administration (Injectables, Oral and Other Modes of Administration), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030

Report Code: PMI484021 | Publish Date: August 2023 | No. of Pages: 168

Global Rare Neurological Disease Treatment Market Companies

  • CSL Ltd
  • Kedrion Biopharma Inc.
  • US WorldMeds LLC (Solstice Neurosciences LLC)
  • Merz Pharma GmbH & Co. KGaA
  • Aquestive Therapeutics Inc.
  • Bayer AG
  • Pfizer Inc.
  • Novartis AG
  • Merck & Co. Inc. (EMD Serono Inc.)
  • Jazz Pharmaceuticals PLC.